By Steve Castellino (Chief Analytics Officer & Principal Investigator - GlycoPath)2025-06-16T09:00:34
What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry imaging (MSI) is making that possible – reshaping drug development from the inside out.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-01-24T08:45:41
Sponsored by Leica Microsystems
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2023-03-08T16:29:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud